Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy
Clinical trial NCT00087503 · COMPLETED
Trial details
- NCT number
- NCT00087503
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.